Position statement on the use of antiretroviral therapy to reduce HIV transmission, January 2013: The British HIV Association (BHIVA) and the Expert Advisory Group on AIDS (EAGA)
暂无分享,去创建一个
J. Anderson | B. Gazzard | D. Churchill | S. Fidler | K. Rogstad | M. Fisher | R. Lowbury | G. Cairns | V. Delpech | N. Gill | Y. Azad | L. Lazarus | K. Radcliffe | C. Evans | B. Osoro | K. Orton | B. Smith
[1] Michael Rayment,et al. Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.
[2] R. Gray,et al. Probability of heterosexual HIV-1 transmission per coital act in sub-Saharan Africa. , 2012, The Journal of infectious diseases.
[3] J. Baeten,et al. Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples. , 2012, The Journal of infectious diseases.
[4] S. Khoo,et al. Pharmacokinetics of Antiretroviral Drugs in Anatomical Sanctuary Sites: The Male and Female Genital Tract , 2011, Antiviral therapy.
[5] R. Hayes,et al. Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning? , 2010, AIDS.
[6] Anne M Johnson,et al. Determinants of HIV-1 transmission in men who have sex with men: a combined clinical, epidemiological and phylogenetic approach , 2010, AIDS.
[7] R. Hayes,et al. Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial. , 2010, The Journal of infectious diseases.
[8] Marie-Claude Boily,et al. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention , 2010, International journal of epidemiology.
[9] H. Curtis,et al. British HIV Association (BHIVA) national cohort outcomes audit of patients commencing antiretrovirals from naïve , 2009, HIV medicine.
[10] Else Smith. [Condom effectiveness in reducing heterosexual HIV transmission]. , 2002, Ugeskrift for laeger.
[11] T. Quinn,et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. , 2000, The New England journal of medicine.